Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics

Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics

Sarcopenia related mobility dysfunction was a preventable presentation in transitional variation of frailty. However, the definition, associated risk factors, clinical course and outcome of sarcopenia in Taiwanese older adults are still under-clarified and need for further study.

Inclusion Criteria:

• functional decline in recent one year
• cognitive impairment
• depressive symptom
• mobility impairment
• fall in recent one year
• eating or feeding problems
• weight loss
• co-morbid conditions≧5
• tracking by different physician ≧3 in recent half year
• poly-pharmacy≧8 in recent 3 months
• hospitalization ≧1 in recent one year
• emergency visits≧2 in recent one year
• aged ≧ 80.

Exclusion Criteria:

• non-ambulatory (bed-ridden) patients
• long-term residents at nursing homes
• patients with a life expectancy shorter than six months
• impairment in vision, hearing, or communicative ability, making convenience of clinical evaluation during the study period impossible.